SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-116918
Filing Date
2021-09-17
Accepted
2021-09-17 16:15:45
Documents
2
Group Members
FFI FUND LTD.FYI LTD.OLIFANT FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2127868d1_sc13g.htm SC 13G 82252
2 EXHIBIT 99.1 tm2127868d1_ex99-1.htm EX-99.1 8290
  Complete submission text file 0001104659-21-116918.txt   92263
Mailing Address 888 BOYLSTON STREET SUITE 1500 BOSTON MA 02199
Business Address 888 BOYLSTON STREET SUITE 1500 BOSTON MA 02199 617-497-3500
Bracebridge Capital, LLC (Filed by) CIK: 0001426486 (see all company filings)

IRS No.: 043344637 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Subject) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91924 | Film No.: 211260602
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences